Aragen is a trusted R&D and manufacturing partner to the global life sciences industry.
Location: United States, Massachusetts, Cambridge
Employees: 1001-5000
Phone: +91 40 6692 9999
Investors 1
| Date | Name | Website |
| - | BroadOak C... | broadoak.c... |
Mentions in press and media 12
| Date | Title | Description |
| 23.09.2024 | PROTACs: Breaking Boundaries in Drug Discovery, Upcoming Webinar Hosted by Xtalks | www.aragen.com/solutions/small-molecules/discovery/integrated-discovery/ In this free webinar, learn proteolysis targeting chimeras (PROTACs) can transform drug discovery by selectively degrading specific proteins. Attendees will learn how ... |
| 27.07.2024 | GVK Power's Insolvency: A Cautionary Tale for India's Infrastructure Sector | In the world of business, the rise and fall of giants often serve as cautionary tales. GVK Power and Infrastructure, once a beacon of hope in India's infrastructure landscape, now finds itself teetering on the brink of insolvency. This saga... |
| 27.07.2024 | The Future of Brain Health: ViewMind's Revolutionary Approach | In the realm of healthcare, innovation is the lifeblood that keeps the industry vibrant. Enter ViewMind, a company that has recently captured the spotlight by winning the 2024 North American Technology Innovation Leadership Award from Frost... |
| 26.07.2024 | GVK power faces insolvency, but GVK group continues interests India to reach 300 MT by 2030 in steel production; Deloitte & ISA 300,000 people left jobless in 10 years post-closing of 49,000 MSMEs... | POWER & RENEWABLE ENERGY GVK power faces insolvency, but GVK group continues interests 26 Jul 2024 5 Min Read CW Team In August 2020, it was announced by GVK Power that it and its subsidiaries involved in airport businesses had reached ... |
| 24.07.2024 | Aragen Life Sciences Ltd. receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery and Development Services | Aragen Life Sciences Ltd. excels in providing end-to-end drug discovery and development solutions, showcasing its innovative approaches and strong commitment to sustainability and customer satisfaction. SAN ANTONIO, July 24, 2024 /PRNewswir... |
| 10.07.2024 | Process Development of New Chemical Entities -- Overcoming Challenges of Safety and Quality for a Seamless Technology Transfer, Upcoming Webinar Hosted by Xtalks | www.aragen.com/solutions/small-molecules/discovery/integrated-discovery In this free webinar, learn about the essential elements of a process development program for new chemical entities. Learn how to develop a robust process in line with ... |
| 27.02.2023 | The Role of Protein Analytics in the Advancement of Biotherapeutic Drug Discovery & Development, Upcoming Webinar Hosted by Xtalks | The webinar will cover current technologies used to assess the qualities of the target biotherapeutics, screening assays for potential biologics and approaches implemented for validating hits. TORONTO (PRWEB) February 27, 2023 Bioanalytical... |
| 15.09.2022 | Driving Better Titers and Shorter Timelines with a Robust and Scalable CHO DG44 Platform, Upcoming Webinar Hosted by Xtalks | Improved process design as well as vector modifications can help address both limitations to improve titers and to achieve faster results for expediting therapeutic objectives. TORONTO (PRWEB) September 15, 2022 Chinese hamster ovary (CHO) ... |
| 11.08.2022 | Brain Metastases – Challenges of Developing Clinically Relevant Preclinical Models, Upcoming Webinar Hosted by Xtalks | Several key modulators in the hostile brain tumor microenvironment promote cancer cell proliferation, apoptosis, metabolism, growth factor signaling, migration and invasion. There is a growing need to understand brain metastases. TORONTO (P... |
| 15.06.2022 | Development of Covalent Drugs with New Emerging Technologies, Upcoming Webinar Hosted by Xtalks | Covalent therapeutics can also be a strategy to overcome drug-resistance mutations in the gene encoding the target protein like in case of the epidermal growth factor receptor (EGFR). TORONTO, Ontario (PRWEB) June 15, 2022 Covalent drugs co... |
Show more